StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Friday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright raised their price objective on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Stock Analysis on SNES
SenesTech Price Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Health Care Stocks Explained: Why You Might Want to Invest
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Insider Buying Explained: What Investors Need to Know
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Calculate Stock Profit
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.